Lensar (LNSR) EBT Margin (2019 - 2026)

Lensar's (LNSR) quarterly EBT Margin came in at 0.31% in Q1 2026, up 15593.0% year-on-year from N/an in Q1 2025, and up 99.82% on a QoQ basis from 178.53% in Q4 2025.

Lensar (LNSR) EBT Margin (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of EBT Margin data on file, last reported at 0.31% in Q1 2026.

  • On a quarterly basis, EBT Margin rose 15593.0% year-over-year to 0.31% in Q1 2026; TTM through Mar 2026 was 121.5%, a 3432.0% decrease from a year earlier, with the FY2025 full-year figure at 70.02%, down 3189.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 0.31%, up from 178.53% in the prior quarter.
  • Over the last five years, EBT Margin for LNSR reached as high as 0.31% in Q1 2026 and fell as low as 2506.9% in Q1 2024.
  • Historically, EBT Margin has averaged 240.1% across 5 years, with a median of 115.6% in 2023.
  • Across the five-year window, EBT Margin plunged 239130 bps in 2024 and surged 235066 bps in 2025, its largest moves.
  • Year by year, EBT Margin stood at 38.02% in 2022, then increased by 15 bps to 32.28% in 2023, then slumped by 175 bps to 88.68% in 2024, then tumbled by 101 bps to 178.53% in 2025, then soared by 100 bps to 0.31% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 0.31% in Q1 2026, 178.53% in Q4 2025, and 161.38% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.98%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 14.12%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 18.70%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 27.84%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 22.61%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 4.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 9.84%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Lensar 70.05 Mn 72.73 Mn 6.38 Mn -0.31%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.31%
Dec 31, 2025 -178.53%
Sep 30, 2025 -161.38%
Jun 30, 2025 -169.63%
Mar 31, 2025 -156.24%
Dec 31, 2024 -88.68%
Sep 30, 2024 -27.23%
Jun 30, 2024 -60.69%
Mar 31, 2024 -2,506.90%
Dec 31, 2023 -32.28%
Sep 30, 2023 -87.76%
Jun 30, 2023 -39.55%
Mar 31, 2023 -115.60%
Dec 31, 2022 -38.02%
Sep 30, 2022 -132.54%
Jun 30, 2022 -168.26%
Mar 31, 2022 -118.08%
Dec 31, 2021 -39.51%
Sep 30, 2021 -165.54%
Jun 30, 2021 -144.15%